Viewing Study NCT01457495


Ignite Creation Date: 2025-12-24 @ 1:29 PM
Ignite Modification Date: 2026-02-21 @ 8:40 AM
Study NCT ID: NCT01457495
Status: COMPLETED
Last Update Posted: 2017-06-16
First Post: 2011-10-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered Concomitantly
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module